279 related articles for article (PubMed ID: 26706603)
1. The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: A retrospective cohort study in the Clinical Practice Research Datalink (CPRD).
Kingswood C; Bolton P; Crawford P; Harland C; Johnson SR; Sampson JR; Shepherd C; Spink J; Demuth D; Lucchese L; Nasuti P; Gray E; Pinnegar A; Magestro M
Eur J Paediatr Neurol; 2016 Mar; 20(2):296-308. PubMed ID: 26706603
[TBL] [Abstract][Full Text] [Related]
2. The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD).
Kingswood JC; Nasuti P; Patel K; Myland M; Siva V; Gray E
J Med Econ; 2016 Dec; 19(12):1116-1126. PubMed ID: 27310569
[TBL] [Abstract][Full Text] [Related]
3. The economic burden of tuberous sclerosis complex in the UK: A retrospective cohort study in the Clinical Practice Research Datalink.
Kingswood JC; Crawford P; Johnson SR; Sampson JR; Shepherd C; Demuth D; Erhard C; Nasuti P; Patel K; Myland M; Pinnegar A; Magestro M; Gray E
J Med Econ; 2016 Nov; 19(11):1087-1098. PubMed ID: 27267148
[TBL] [Abstract][Full Text] [Related]
4. Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD).
Shepherd C; Koepp M; Myland M; Patel K; Miglio C; Siva V; Gray E; Neary M
BMJ Open; 2017 Oct; 7(10):e015236. PubMed ID: 28982809
[TBL] [Abstract][Full Text] [Related]
5. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature.
Adriaensen ME; Schaefer-Prokop CM; Stijnen T; Duyndam DA; Zonnenberg BA; Prokop M
Eur J Neurol; 2009 Jun; 16(6):691-6. PubMed ID: 19236458
[TBL] [Abstract][Full Text] [Related]
7. Direct and indirect costs and cost-driving factors in adults with tuberous sclerosis complex: a multicenter cohort study and a review of the literature.
Zöllner JP; Grau J; Rosenow F; Sauter M; Knuf M; Kurlemann G; Mayer T; Hertzberg C; Bertsche A; Immisch I; Klein KM; Knake S; Marquard K; Meyer S; Noda AH; von Podewils F; Schäfer H; Thiels C; Willems LM; Zukunft B; Schubert-Bast S; Strzelczyk A
Orphanet J Rare Dis; 2021 Jun; 16(1):250. PubMed ID: 34078440
[TBL] [Abstract][Full Text] [Related]
8. Genotype/phenotype in tuberous sclerosis complex: associations with clinical and radiologic manifestations.
Kothare SV; Singh K; Hochman T; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
Epilepsia; 2014 Jul; 55(7):1020-4. PubMed ID: 24754401
[TBL] [Abstract][Full Text] [Related]
9. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
[TBL] [Abstract][Full Text] [Related]
10. Direct medical costs for patients with tuberous sclerosis complex and surgical resection of subependymal giant cell astrocytoma: a US national cohort study.
Sun P; Liu Z; Krueger D; Kohrman M
J Med Econ; 2015 May; 18(5):349-56. PubMed ID: 25525770
[TBL] [Abstract][Full Text] [Related]
11. Manifestations of Tuberous Sclerosis Complex: The Experience of a Provincial Clinic.
Wilbur C; Sanguansermsri C; Chable H; Anghelina M; Peinhof S; Anderson K; Steinbok P; Singhal A; Datta A; Connolly MB
Can J Neurol Sci; 2017 Jan; 44(1):35-43. PubMed ID: 28004629
[TBL] [Abstract][Full Text] [Related]
12. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
[TBL] [Abstract][Full Text] [Related]
13. Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.
Tsai JD; Wei CC; Tsao TF; Hsiao YP; Tsai HJ; Yang SH; Tsai ML; Sheu JN
Childs Nerv Syst; 2016 Jan; 32(1):89-95. PubMed ID: 26552385
[TBL] [Abstract][Full Text] [Related]
14. Description of a multidisciplinary model of care in a French cohort of adult patients with tuberous sclerosis complex.
Pfirmann P; Aupy J; Jambon E; Idier L; Prezelin-Reydit M; Fermis M; Devillard R; Grenier N; Combe C; Rigothier C
J Med Genet; 2021 Jan; 58(1):25-31. PubMed ID: 32409510
[TBL] [Abstract][Full Text] [Related]
15. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
[TBL] [Abstract][Full Text] [Related]
16. Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients.
Wataya-Kaneda M; Tanaka M; Hamasaki T; Katayama I
PLoS One; 2013; 8(5):e63910. PubMed ID: 23691114
[TBL] [Abstract][Full Text] [Related]
17. Healthcare utilization and costs in patients with tuberous sclerosiscomplex-related renal angiomyolipoma.
Song X; Liu Z; Cappell K; Gregory C; Said Q; Prestifilippo J; Charles H; Hulbert J; Bissler J
J Med Econ; 2017 Apr; 20(4):388-394. PubMed ID: 27998195
[TBL] [Abstract][Full Text] [Related]
18. EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Fogarasi A; De Waele L; Bartalini G; Jozwiak S; Laforgia N; Verhelst H; Petrak B; Pedespan JM; Witt O; Castellana R; Crippa S; Gislimberti G; Gyorsok Z
BMC Neurol; 2016 Aug; 16():126. PubMed ID: 27502586
[TBL] [Abstract][Full Text] [Related]
19. Different MRI-defined tuber types in tuberous sclerosis complex: Quantitative evaluation and association with disease manifestations.
Jesmanas S; Norvainytė K; Gleiznienė R; Šimoliūnienė R; Endzinienė M
Brain Dev; 2018 Mar; 40(3):196-204. PubMed ID: 29258718
[TBL] [Abstract][Full Text] [Related]
20. Epileptic spasms in tuberous sclerosis complex.
Hsieh DT; Jennesson MM; Thiele EA
Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
